FindTrial
Sign In

Predicting acute intracerebral hemorrhage expansion and poor prognosis using multimodal CT and clinical indicators

Analyzing the risk of acute intracerebral hemorrhage expansion and poor prognosis based on multimodal imaging and clinical parameters

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064360
Enrollment
Unknown
Registered
2022-10-04
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracerebral hemorrhage

Interventions

Hematoma expansion / non-expansion group:None
Good/poor prognosis group:None

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. The patients were diagnosed as spontaneous intracranial hemorrhage patients; 2. Underwent baseline CT examination within 6 hours of symptom onset; 3. Underwent follow-up CT examination within 72 hours of symptom onset; 4. The patients were aged >18 years.

Exclusion criteria

Exclusion criteria: 1. Traumatic ICH or hemorrhagic transformation of ischemic stroke; 2. Tumor, aneurysm, or arteriovenous malformation presumed to be the potential cause of the bleeding; 3. Primary intraventricular hemorrhage; 4. Surgical intervention before the follow-up CT; 6. Severe artifacts on the original image.

Design outcomes

Primary

MeasureTime frame
Activity of Daily Living Scale;hematoma expasion;—

Countries

China

Contacts

Public ContactYunjun Yang

The First Affiliated Hospital of Wenzhou Medical University

yyjunjim@163.com+86 577 55578779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 28, 2026